Literature DB >> 8231643

Ketamine inhibition of cytoplasmic calcium signalling in rat pheochromocytoma (PC-12) cells.

B S Wong1, C D Martin.   

Abstract

This study examines the mechanism of action of ketamine, a dissociative anesthetic, with a specific focus on its ability to inhibit changes in the concentration of intracellular free calcium, [Ca2+]i, in PC-12 cells. The resting [Ca2+]i as measured with the fluorescent probe Fura-2 AM in control cells is 184.8 +/- 8.6 nM (mean +/- SEM, n = 15). Changes in [Ca2+]i via influx through voltage-gated calcium channels after membrane depolarization with potassium chloride were monitored in the absence and presence of various concentrations of ketamine. Potassium-depolarization caused a dose-dependent rapid increase in [Ca2+]i, averaging 62 +/- 5%, 33 +/- 2% and 18 +/- 3% (n = 10 each) above control levels for 70 mM, 50 mM and 35 mM KCl, respectively. Ketamine, in the dosage range studied (5-500 microM), inhibited the increase in [Ca2+]i stimulated by potassium-depolarization in a dose-dependent manner. The computer-fitted dose-response curve of the pooled data yielded a half maximal suppression concentration, ED50, of 33 microM. In conclusion, this study demonstrates that ketamine inhibits Ca2+ influx through voltage-gated Ca2+ channels in PC-12 cells at clinically relevant doses, and may play a role in ketamine's action as a general anesthetic agent.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8231643     DOI: 10.1016/0024-3205(93)90210-t

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Mapping the central effects of ketamine in the rat using pharmacological MRI.

Authors:  Clare L Littlewood; Nicholas Jones; Michael J O'Neill; Stephen N Mitchell; Mark Tricklebank; Steven C R Williams
Journal:  Psychopharmacology (Berl)       Date:  2006-03-21       Impact factor: 4.530

Review 2.  Ketamine in pain management.

Authors:  Jan Persson
Journal:  CNS Neurosci Ther       Date:  2013-05-11       Impact factor: 5.243

3.  The Combination of Tissue-Engineered Blood Vessel Constructs and Parallel Flow Chamber Provides a Potential Alternative to In Vivo Drug Testing Models.

Authors:  Wanjiku Njoroge; Andrea C Hernández Hernández; Faiza Idris Musa; Robert Butler; Alan G S Harper; Ying Yang
Journal:  Pharmaceutics       Date:  2021-03-05       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.